Federal Drug Patent Grab Means Fewer New Medicines: Think Tank (1)

March 4, 2019, 8:32 PM; Updated: March 4, 2019, 9:12 PM

Fewer new medicines would come onto the market if the NIH exercised its rights to commandeer drug patents as a way of combating high drug prices, according to a think tank.

The report released March 4 from the Information Technology and Innovation Foundation (ITIF) is a win for the drug industry, which continues to face criticism on Capitol Hill for the rising costs of prescription drugs. Lawmakers and the White House are considering a number of policy options to bring down drug prices, and the use of National Institutes of Health funds in drug development has come up ...

To read the full article log in.